Eliot Forster’s pain biotech un­veils Phase 2 da­ta in de­gen­er­a­tive joint dis­ease

UK biotech Lev­i­cept said its first-in-class bi­o­log­ic can help ease pain and stiff­ness in pa­tients with mod­er­ate to se­vere os­teoarthri­tis, ac­cord­ing to mid-stage da­ta re­leased …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER